| Literature DB >> 30367605 |
Pengcheng Huai1,2,3, Furong Li2, Zhen Li2, Lele Sun2,4, Xi'an Fu2,4, Qing Pan2,4, Gongqi Yu2,4, Zemin Chai2,4, Tongsheng Chu2, Zihao Mi2,4, Fangfang Bao2,4, Honglei Wang2,4, Bingni Zhou2,4, Chuan Wang2,4, Yonghu Sun2,4, Guiye Niu2,4, Yuan Zhang2,4, Fanghui Fu2,4, Xiaoqiao Lang2,4, Xiaoling Wang2,4, Hui Zhao2,4, Daina Liu2,4, Hong Liu2,4, Dianchang Liu2, Jian Liu2, Aiqiang Xu3,5, Furen Zhang6,7.
Abstract
BACKGROUND: A population-based study of Chlamydia trachomatis (CT) infections is essential in designing a specific control program; however, no large investigation of CT infections among the general population in mainland China has been conducted since 2000. We aimed to determine the prevalence, risk factors, and associated medical costs of CT among residents, 18-49 years of age, in Shandong, China.Entities:
Keywords: China; Chlamydia trachomatis; General population; Medical cost; Neisseria gonorrhea; Prevalence; Risk factor
Mesh:
Year: 2018 PMID: 30367605 PMCID: PMC6204023 DOI: 10.1186/s12879-018-3432-y
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Geographic locations of Shandong Province and 12 primary sampling units
Fig. 2The method of calculating the medical costs of CT infection for females. Abbreviations: PID pelvic inflammatory disease, CT Chlamydia trachomatis
Fig. 3The method of calculating the medical costs of CT infection for males. Abbreviations: CT Chlamydia trachomatis
Fig. 4Flow chart for participant selection. Abbreviations: CT Chlamydia trachomatis, NG neisseria gonorrhoeae
The weighted prevalence of CT and NG in participants 18–49 years of age in Shandong, China
| Male [n, %(95%CI)] | Female [n, %(95%CI)] | Denominatora (unweighted, weightedb) | ||||
|---|---|---|---|---|---|---|
| CT | NG | CT | NG | Male | Female | |
| Age(years) | ||||||
| 18–24 | 11, 4.3% (0.0–8.8) | 0, 0.0% | 7, 3.2% (0.4–6.1) | 1, 0.2% (0.0–0.6) | 253, 851 | 194, 825 |
| 25–29 | 18, 2.3% (0.5–4.1) | 0, 0.0% | 24, 2.9% (1.9–3.8) | 0, 0.0% | 780, 496 | 914, 499 |
| 30–34 | 13, 2.8% (1.3–4.2) | 0, 0.0% | 20, 3.5% (2.6–4.4) | 1, 0.1% (0.0–0.2) | 500, 469 | 555, 461 |
| 35–39 | 13, 2.7% (1.1–4.2) | 0, 0.0% | 8, 1.4% (0.4–2.4) | 1, 0.1% (0.0–0.3) | 557, 567 | 588, 559 |
| 40–44 | 15, 2.4% (1.3–3.5) | 0, 0.0% | 14, 1.5% (0.4–2.6) | 1, 0.1% (0.0–0.4) | 713, 667 | 735, 659 |
| 45–49 | 7, 0.8% (0.2–1.3) | 1, 0.2% (0.0–0.5) | 17, 1.6% (0.9–2.4) | 1, 0.1% (0.0–0.3) | 692, 572 | 722, 578 |
| Region | ||||||
| Northwest | 4, 3.0% (0.0–7.7) | 0, 0.0% | 7, 1.6% (0.6–2.5) | 0, 0.0% | 338, 390 | 348, 356 |
| Middle | 28, 3.0% (1.1–4.9) | 0, 0.0% | 17, 2.0% (0.0–4.6) | 0, 0.0% | 895, 941 | 907, 851 |
| South | 29, 2.7% (1.7–3.8) | 1, 0.1% (0.0–0.2) | 46, 3.0% (2.2–3.9) | 2, 0.1% (0.0–0.5) | 1489, 1456 | 1567, 1479 |
| East | 16, 2.0% (1.3–2.7) | 0, 0.0% | 20, 1.8% (1.1–2.5) | 3, 0.2% (0.0–0.5) | 773, 835 | 886, 895 |
| Total | 77, 2.7% (1.6–3.8) | 1, 0.03% (0.0–0.1) | 90, 2.3% (1.5–3.2) | 5, 0.1% (0.0–0.3) | 3495, 3622 | 3708, 3581 |
Abbreviations: CI confidence interval, CT chlamydia trachomatis, NG neisseria gonorrhoeae
aDenominator was participants with sex experience and a urine test result
bSelection probability weighting, non-response weighting, and post-stratification weighting were applied to calculate the weighted denominator
Risk factors for CT in urine specimens from participants 18–49 years of age in Shandong, China
| Male | Female | Denominatorc unweighted, weighted | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| % (95% CI) | Crude OR | Adjusted ORa | 95% CI | % (95% CI) | Crude OR | Adjusted ORb | 95% CI | Male | Female | |
| All ages | 2.7% (1.6–3.8) | 2.3% (1.5–3.2) | 3495, 3622 | 3708, 3581 | ||||||
| Age(years) | ||||||||||
| 18–24 | 4.3% (0.0–8.8) | 1.00 | 1.00 | 1.00–1.00 | 3.2% (0.4–6.1) | 1.00 | 1.00 | 1.00–1.00 | 253, 851 | 194, 825 |
| 25–29 | 2.3% (0.5–4.1) | 0.52 | 0.91 | 0.24–3.48 | 2.9% (1.9–3.8) | 0.88 | 2.23 | 0.72–6.86 | 780, 496 | 914, 499 |
| 30–34 | 2.8% (1.3–4.2) | 0.63 | 1.40 | 0.37–5.35 | 3.5% (2.6–4.4) | 1.08 | 3.74 | 1.09–12.83 | 500, 469 | 555, 461 |
| 35–39 | 2.7% (1.1–4.2) | 0.61 | 1.40 | 0.37–5.21 | 1.4% (0.4–2.4) | 0.42 | 1.54 | 0.58–4.06 | 557, 567 | 588, 559 |
| 40–44 | 2.4% (1.3–3.5) | 0.54 | 1.32 | 0.54–3.24 | 1.5% (0.4–2.6) | 0.46 | 1.48 | 0.45–4.86 | 713, 667 | 735, 659 |
| 45–49 | 0.8% (0.2–1.3) | 0.17 | 0.40 | 0.15–1.03 | 1.6% (0.9–2.4) | 0.50 | 1.81 | 0.60–5.45 | 692, 572 | 722, 578 |
| Education | ||||||||||
| Elementary school, or below | 3.2% (0.0–8.3) | 1.00 | – | – | 1.6% (1.1–2.2) | 1.00 | 1.00 | 1.00–1.00 | 367, 330 | 806, 697 |
| Middle school | 2.5% (1.4–3.5) | 0.75 | – | – | 1.8% (1.2–2.3) | 1.08 | 1.04 | 0.69–1.55 | 1906, 1830 | 1935, 1788 |
| Senior high school or technical school | 3.3% (1.6–5.0) | 1.02 | – | – | 3.1% (0.8–5.3) | 1.90 | 1.52 | 0.80–2.92 | 920, 1040 | 669, 752 |
| College, university, or above | 1.4% (0.0–3.1) | 0.44 | – | – | 5.2% (0.0–10.6) | 3.32 | 2.11 | 0.93–4.81 | 302, 422 | 298, 344 |
| Marital status | ||||||||||
| Married | 2.1% (1.5–2.8) | 1.00 | 1.00 | 1.00–1.00 | 1.8% (1.2–2.4) | 1.00 | 1.00 | 1.00–1.00 | 3164, 3043 | 3528, 3253 |
| Unmarried, divorced or widowed | 5.4% (0.9–9.9) | 2.61 | 1.45 | 0.55–3.84 | 7.8% (1.4–14.3) | 4.65 | 3.64 | 1.63–8.13 | 331, 579 | 180, 328 |
| Location of residence | ||||||||||
| urban | 2.8% (1.1–4.5) | 1.00 | – | – | 2.8% (1.0–4.5) | 1.00 | – | – | 1708, 2063 | 1824, 2040 |
| rural | 2.5% (1.2–3.9) | 0.91 | – | – | 1.8% (1.3–2.2) | 0.64 | – | – | 1787, 1559 | 1884, 3581 |
| Living status | ||||||||||
| living with family | 2.3% (1.5–3.1) | 1.00 | 1.00 | 1.00–1.00 | 2.3% (1.4–3.2) | 1.00 | – | – | 3279, 3327 | 3538, 3320 |
| living with roommates | 6.5% (0.0–17.8) | 2.99 | 2.20 | 0.53–9.19 | 2.9% (0.0–9.3) | 1.29 | – | – | 69, 99 | 54, 108 |
| living alone | 7.3% (0.0–16.4) | 3.38 | 1.77 | 0.50–6.22 | 2.8% (0.0–6.0) | 1.21 | – | – | 147, 196 | 116, 153 |
| Living with spoused | ||||||||||
| Yes | 1.9% (1.5–2.3) | 1.00 | – | – | 1.8% (1.1–2.5) | 1.00 | – | – | 3080, 3149 | 3309, 3213 |
| No | 10.4% (0.0–24.6) | 5.93 | – | – | 1.9% (0.3–3.5) | 1.06 | – | – | 84, 86 | 219, 244 |
| Smoking | ||||||||||
| No | 2.1% (0.9–3.3) | 1.00 | 1.00 | 1.00–1.00 | 2.3% (1.5–3.1) | 1.00 | – | – | 1747, 1785 | 3309, 3527 |
| Yes | 3.2% (1.5–4.9) | 1.58 | 1.36 | 0.65–2.86 | 5.9% (0.0–16.5) | 2.68 | – | – | 1748, 1837 | 70, 54 |
| STI in the past 5 yearse | ||||||||||
| No | 2.5% (1.4–3.6) | 1.00 | 1.00 | 1.00–1.00 | 2.3% (1.5–3.1) | 1.00 | 1.00 | 1.00–1.00 | 3467, 3595 | 3697, 3572 |
| Yes | 21.1% (0.0–54.8) | 10.3 | 7.65 | 0.79–73.84 | 9.0% (0.0–28.4) | 4.15 | 6.21 | 0.58–66.18 | 19, 27 | 11, 9 |
| Age at first intercourse (years) | ||||||||||
| >20 | 1.8% (1.4–2.3) | 1.00 | 1.00 | 1.00–1.00 | 1.9% (1.2–2.6) | 1.00 | 1.00 | 1.00–1.00 | 2698, 2549 | 3308, 3000 |
| ≤ 20 | 4.6% (1.0–8.2) | 2.58 | 1.76 | 1.05–2.94 | 4.7% (2.5–7.0) | 2.59 | 1.94 | 0.64–5.90 | 797, 1073 | 400, 581 |
| Number of sex partners | ||||||||||
| 1 | 2.1% (1.5–2.8) | 1.00 | 1.00 | 1.00–1.00 | 2.0% (1.2–2.7) | 1.00 | 1.00 | 1.00–1.00 | 3086, 3107 | 3597, 3441 |
| ≥ 2 | 6.0% (1.5–10.4) | 2.92 | 2.09 | 1.10–3.94 | 11.5% (0.0–23.3) | 6.47 | 3.66 | 1.07–12.48 | 409, 515 | 111, 140 |
| Number of new sex partners in the past year | ||||||||||
| ≤ 1 | 2.5% (1.4–3.7) | 1.00 | 1.00 | 1.00–1.00 | 2.3% (1.5–3.1) | 1.00 | – | – | 3375, 3459 | 3678, 3549 |
| ≥ 2 | 5.2% (0.5–9.8) | 2.08 | 0.56 | 0.15–2.16 | 5.0% (0.0–12.0) | 2.21 | – | – | 120, 163 | 30, 32 |
Abbreviations: CT Chlamydia trachomatis, CI confidence interval, OR odds ratio, AOR adjusted odds ratio, STI sexually transmitted infection
aAdjusted for age, marital status, living status, smoking, STI in the past 5 years, age at first intercourse, number of sex partners, number of new sex partners in the past year and smoking
bAdjusted for age, education, marital status, STI in the past 5 years, age at first intercourse and number of sex partners
cDenominator was participants with sex experience and a urine test result
dThis variable included those who have been married
eSTIs included syphilis, gonorrhea, chlamydia trachomatis infection, condyloma acuminatum, genital herpes, and HIV infection